FDA Approved Nicotine Pouches? Authorized, Not Approved: All 43 Products (2026)

FDA Approved Nicotine Pouches? Authorized, Not Approved: All 43 Products (2026)

If you searched "FDA approved nicotine pouches," you found the right page but the wrong word. As of August 21, 2026, exactly 43 nicotine pouch products hold FDA marketing granted orders, spanning two manufacturers and four product lines: ZYN (20), ZYN ULTRA (11), on! (6), and on! PLUS (6). No other nicotine pouch is authorized for sale in the United States. And "authorized" is the right word, not "approved," a distinction the FDA itself insists on. Here is every product on that list, when it was authorized, and what the authorization actually means.

For a broader look at every nicotine pouch brand compared, including brands still waiting on FDA decisions, see our full brand guide.

Every FDA-Authorized Nicotine Pouch (Complete Table)

Last verified against FDA's authorized nicotine pouch page: August 21, 2026.

Swedish Match USA, Inc. (Philip Morris International)

Swedish Match total: 31 products (20 ZYN + 11 ZYN ULTRA)

Helix Innovations LLC (Altria Group)

Helix total: 12 products (6 on! + 6 on! PLUS)

*FDA has not published an exact authorization date for these two products. They appear on the authorized list as of Aug 21, 2026, but no FDA newsroom release or Altria press statement names a specific date.

Grand total: 43 authorized nicotine pouch products.

Authorization Timeline

The path to 43 took about 20 months:

• January 16, 2025: FDA issues the first-ever nicotine pouch marketing granted orders to 20 ZYN products (10 flavors, each at 3 mg and 6 mg). Applicant: Swedish Match USA, a Philip Morris International subsidiary.
• December 19, 2025: FDA authorizes 6 on! PLUS products (Mint, Tobacco, Wintergreen at 6 mg and 9 mg). These are the first decisions from the nicotine pouch pilot program. Applicant: Helix Innovations, an Altria subsidiary.
• June 30, 2026: FDA grants Modified Risk Tobacco Product (MRTP) orders to the same 20 ZYN products. This is a separate order type, not a new product authorization. It lets ZYN market a specific health claim (see below).
• August 4, 2026: FDA authorizes 4 on! products (Rich Berry 2 mg, Cappuccino 2 mg, Cappuccino 4 mg, Autumn Spice 2 mg) through the pilot program.
• Between August 5 and August 21, 2026: Two more on! products (Autumn Spice 4 mg, Rich Berry 4 mg) appear on the authorized list. No exact date published by FDA.
• August 21, 2026: FDA authorizes 11 ZYN ULTRA products (10 flavors at 9 mg, plus Smooth at 11 mg). The total reaches 43, with 23 authorized through the pilot program.

For a detailed breakdown of how ZYN Ultra compares to classic ZYN, see our side-by-side review.

Marketing Granted Order vs. Modified Risk Order vs. "FDA Approved"

These three phrases mean very different things. Conflating them is the single most common error in nicotine pouch marketing.

Marketing Granted Order (MGO): The product passed FDA's premarket tobacco product application (PMTA) review. FDA determined the product is "appropriate for the protection of the public health." All 43 authorized pouches hold one. An MGO lets a manufacturer legally sell the product. It does not mean FDA considers the product safe, beneficial, or endorsed.

Modified Risk Tobacco Product (MRTP) Order: A second, separate process. The manufacturer submits evidence that the product poses lower risk than a specified comparator (usually cigarettes). Only 20 products hold one: the classic ZYN 3 mg and 6 mg line. The authorized claim reads: "Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis." ZYN ULTRA does not hold an MRTP order.

"FDA Approved": This phrase does not apply to any tobacco product, period. FDA's own disclaimer on the authorized list page states: "While these products are authorized to be sold in the United States, it does not mean these products are safe, nor are they 'FDA approved.'" If a brand uses "FDA approved" in its marketing, that brand is wrong.

Which Best-Selling Pouches Are NOT on This List

Here is the part that surprises most buyers: several of the top-selling nicotine pouch products in the U.S. are not FDA-authorized.

on! core flavors. The on! products most people actually buy, Mint, Wintergreen, Cinnamon, Citrus, Coffee, and Original at 2, 4, and 8 mg, are not on the authorized list. Only three flavored on! lines (Autumn Spice, Cappuccino, Rich Berry at 2 and 4 mg) and the on! PLUS line (Mint, Tobacco, Wintergreen at 6 and 9 mg) hold marketing granted orders. The popular on! PLUS 12 mg is also not authorized. For a full breakdown of on!'s lineup measured against ZYN, see our comparison.

VELO and VELO Plus. R.J. Reynolds Vapor (BAT) filed PMTAs by the September 2020 deadline. As of July 2026, no marketing granted order has been issued. VELO remains on shelves under FDA's enforcement-discretion policy. For background on why Velo isn't on this list yet, see our comparison.

Rogue. Rogue Holdings (a Swisher International and Avema Pharma Solutions joint venture) filed a PMTA in 2020. No authorization to date. More on Rogue's pending authorization status.

Lucy, FRE, CLEW, and others. Lucy Goods and FRE (Turning Point Brands) have reported pending PMTAs. CLEW (Nevcore Innovations) had its PMTA accepted for review in June 2024. ALP, Zone, Juice Head, Sesh+, Grizzly, and Black Buffalo are also absent; their application statuses are unverified.

None of these products are illegal. FDA's May 8, 2026 guidance clarified that products with pending PMTAs may remain on the market under the agency's enforcement-discretion policy. "Not authorized" and "banned" are not the same thing.

The Pilot Program

Twenty-three of the 43 authorized products came through FDA's nicotine pouch PMTA pilot program, launched in September 2025. The pilot streamlined review timelines and reduced back-and-forth between applicants and reviewers. All 12 Helix products and all 11 ZYN ULTRA products were reviewed under it. FDA says it will apply the pilot's efficiencies to other pending PMTAs but has given no public timeline for further decisions.

How to Check a Specific Product

Go to FDA's authorized nicotine pouch page. FDA updates it the day of any new authorization. For the most granular lookup, the Searchable Tobacco Products Database is updated the day after. If a product is not in either place, it does not hold a marketing granted order, regardless of what the brand's website says.

The Regulatory Picture in 2026

The 43 authorized products represent two companies (Swedish Match/PMI and Helix/Altria), both Big Tobacco subsidiaries. Every independent or smaller manufacturer, VELO's parent BAT included, is still waiting. A July 2026 federal court ruling found that FDA likely failed to assess the PMTA rule's economic impact on small pouch manufacturers, which could reshape the timeline for pending applications. For now, the list is 43, and it changes only when FDA says it does.

For a broader ranking, see how these brands rank overall.

Conclusion

Forty-three nicotine pouch products hold FDA marketing granted orders as of August 2026, all from two Big Tobacco subsidiaries. Twenty of those also carry a Modified Risk Tobacco Product order. Every other brand on the market, including VELO, Rogue, and dozens of smaller manufacturers, is selling under enforcement discretion while applications are pending. "Authorized" is not "approved," and "not authorized" is not "banned." Check the FDA's authorized list directly before relying on any brand's own claims.

Frequently Asked Questions

Is ZYN FDA approved?

No tobacco product is "FDA approved." ZYN holds marketing granted orders for 20 products (10 flavors at 3 mg and 6 mg), issued January 16, 2025. Those same 20 products also hold Modified Risk Tobacco Product orders as of June 30, 2026. The correct term is "authorized," not "approved." FDA states this explicitly on its own list page.

Is ZYN Ultra FDA authorized?

Yes. Eleven ZYN ULTRA products received marketing granted orders on August 21, 2026 (10 flavors at 9 mg, plus Smooth at 11 mg). ZYN ULTRA does not hold a Modified Risk Tobacco Product order; that applies only to the classic ZYN 3 mg/6 mg line.

Is VELO FDA approved?

No. VELO (R.J. Reynolds Vapor, BAT) filed PMTAs by the September 2020 deadline, but FDA has not issued a marketing granted order for any VELO product as of this writing. VELO products remain on the market under FDA's enforcement-discretion policy while the application is under review.

Is Rogue FDA approved?

No. Rogue filed a PMTA in 2020, and it remains pending. Like VELO, Rogue is sold under enforcement discretion. No authorization has been issued.

What does "modified risk" mean for ZYN?

The MRTP order, granted June 30, 2026, allows Swedish Match to market the 20 classic ZYN products with the specific claim: "Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis." It does not mean ZYN is safe in absolute terms. The claim is narrowly comparative, against cigarettes only, and does not extend to ZYN ULTRA.

Are caffeine pouches FDA approved?

Caffeine pouches are not tobacco products, so they are not subject to the PMTA process at all. They fall under dietary supplement and food regulation, where FDA does not pre-approve products before sale. A caffeine pouch on the market is not "FDA approved" in any regulatory sense, but it was also never required to be.

What FDA Authorization Actually Certifies, and What Roon Skips Entirely

You just read through 43 products, four order types, a pilot program, and a list of best-sellers that aren't on the list at all. The takeaway: FDA authorization for nicotine pouches certifies that a tobacco product passed a premarket review. It does not certify safety, quality, or endorsement.

Roon sits outside this entire framework. It contains zero nicotine, so no PMTA or MRTP review ever applied to it. Roon is a caffeine dietary supplement, and FDA does not pre-approve supplements before sale. Roon is a nicotine-free, zero-calorie caffeine pouch with a stated formula of 80 mg caffeine, 60 mg L-theanine, 25 mg methylliberine (Dynamine), and 5 mg theacrine (TeaCrine).

Roon is not a nicotine product and not a substitute for one. It is a different pouch for a different reason. Tins start at $9.16 on a 12-tin subscription, $0.61 per pouch.

Related from Roon

• https://www.takeroon.com/blog/nicotine-pouch-brands-complete-guide
• https://www.takeroon.com/blog/best-nicotine-pouches-top-brands-ranked
• https://www.takeroon.com/blog/zyn-ultra-review-vs-regular-zyn
• https://www.takeroon.com/blog/on-vs-zyn-nicotine-pouch-comparison

Written by Roon Team